Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “lung cancer”
- Small Cell Lung Cancer Community Engagement to Eliminate Research DiscepanciesActive Not Recruiting
Sponsor: Addario Lung Cancer Medical Institute
Small-cell Lung Cancer
United States
- Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung CancerRecruiting
Sponsor: Genmab
Non-small Cell Lung Cancer (NSCLC)
United States, Australia, Belgium, China, France +7 more
- Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural MesotheliomaActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Epithelioid Mesothelioma · Pleural Malignant Mesothelioma · Recurrent Malignant Mesothelioma · Sarcomatoid Mesothelioma
United States
Sponsor: Anhui Provincial Cancer Hospital
Squamous Non-Small Cell Lung Cancer sqNSCLC · Extensive-stage Small Cell Lung Cancer (ES-SCLC)
China
Sponsor: AstraZeneca
Limited Stage Small-Cell Lung Cancer
China
- JS207Combined With Chemotherapy in First-line Treatment of Advanced NSCLCActive Not Recruiting
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Non-small Cell Lung Cancer
China
Sponsor: Istituto Oncologico Veneto IRCCS
Carcinoma, Non-small Cell Lung Cancer (NSCLC)
Italy
Sponsor: Addario Lung Cancer Medical Institute
NSCLC
United States
- Trametinib and Docetaxel in Treating Patients With Recurrent or Stage IV KRAS Mutation Positive Non-small Cell Lung CancerActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
KRAS Gene Mutation · Recurrent Lung Non-Small Cell Carcinoma · Stage IV Lung Non-Small Cell Cancer AJCC v7
United States
- Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid TumorsActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Functioning Pancreatic Neuroendocrine Tumor · Intermediate Grade Lung Neuroendocrine Neoplasm · Locally Advanced Digestive System Neuroendocrine Neoplasm · Locally Advanced Digestive System Neuroendocrine Tumor G1
United States
Sponsor: National Cancer Institute (NCI)
Advanced Lung Non-Small Cell Carcinoma · Recurrent Lung Non-Small Cell Carcinoma · Stage IIIB Lung Non-Small Cell Cancer AJCC v7 · Stage IV Lung Non-Small Cell Cancer AJCC v7
United States
- Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung CancerActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Lung Non-Squamous Non-Small Cell Carcinoma · Stage IIIB Lung Cancer AJCC v8 · Stage IIIC Lung Cancer AJCC v8 · Stage IV Lung Cancer AJCC v8
United States, Canada, Guam
- NCI COVID-19 in Cancer Patients, NCCAPS StudyActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
COVID-19 Infection · Hematopoietic and Lymphatic System Neoplasm · Malignant Solid Neoplasm · Metastatic Malignant Solid Neoplasm
United States, Canada, Puerto Rico
- Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)Recruiting
Sponsor: Genmab
High Grade Epithelial Ovarian Cancer · High Grade Serous Ovarian Cancer · Primary Peritoneal Carcinoma · Fallopian Tube Cancer
United States, China, Japan
- Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)Active Not Recruiting
Sponsor: National Cancer Institute (NCI)
Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Stage II Lung Non-Small Cell Cancer AJCC v7 · Stage IIIA Lung Non-Small Cell Cancer AJCC v7
United States
Sponsor: Addario Lung Cancer Medical Institute
Small Cell Lung Cancer ( SCLC ) · Lambert Eaton Myasthenic Syndrome (LEMS)
United States
Sponsor: Hackensack Meridian Health
Lung Cancer
United States
- Amivantamab Combined With Intrathecal Pemetrexed for LM From EGFR-Mutated Lung AdenocarcinomaRecruiting
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Leptomeningeal Metastasis From Lung Cancer
China
- Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)Active Not Recruiting
Sponsor: Genmab
PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC
United States, Argentina, Australia, Austria, Belgium +22 more
Sponsor: Beijing Biotech
Small Cell Lung Cancer (SCLC) · Relapsed/Refractory SCLC · Extensive-stage SCLC
China
Sponsor: Takeda
IO-resistant sqNSCLC
United States, China, Japan
- Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung CancerActive Not Recruiting
Sponsor: National Cancer Institute (NCI)
Metastatic Lung Non-Squamous Non-Small Cell Carcinoma · Recurrent Lung Non-Squamous Non-Small Cell Carcinoma · Stage IV Lung Cancer AJCC v8
United States
- A Study to Test How BI 765063 and BI 770371 Are Taken up in Tumours of People With Different Types of Advanced Cancer Who Are Also Taking EzabenlimabActive Not Recruiting
Sponsor: Boehringer Ingelheim
Carcinoma, Squamous Cell of Head and Neck (HNSCC) · Melanoma · Non-small Cell Lung Cancer (NSCLC)
Netherlands
- Safety and Efficacy of Multimodal Thermal Therapy (MTT) Combined With KRAS G12V mRNA Vaccine, S-1, and Sintilimab in Patients With Metastatic Pancreatic CancerNot Yet Recruiting
Sponsor: Ruijin Hospital
Pancreatic Ductal Adenocarcinoma · Liver Neoplasms · Lung Neoplasms
China
Sponsor: Boehringer Ingelheim
Small Cell Lung Carcinoma (SCLC) · Neuroendocrine Neoplasms
Belgium, France, Germany, Japan